A comparison of methods for classifying samples as truly specific with confirmatory immunoassays

Area of Science:

• Biotechnology
• Immunology
• Pharmacology

Background:

• Biotechnology-derived therapeutics can trigger immune responses, forming anti-drug antibodies (ADAs).
• ADAs can impact therapeutic protein efficacy and safety, potentially causing autoimmunity.
• Reliable assays are essential for detecting and characterizing ADAs.

Purpose of the Study:

• To evaluate the performance of various statistical methods for classifying samples in ADA competition assays.
• To assess the impact of assay variability on the reliability of ADA detection.

Main Methods:

• Simulations were used to test different statistical classification methods.
• Real-world data analysis was performed on competition assay results.
• Performance was evaluated based on the ability to distinguish true ADA-positive from false-positive samples.

Main Results:

• No single statistical method was universally superior, but a t-test demonstrated consistent good performance.
• High assay variability significantly reduces the ability to obtain meaningful classification results.
• Substantial differences between inhibited and uninhibited measurements are needed for reliable classification.

Conclusions:

• The effectiveness of ADA competition assays is highly dependent on minimizing assay variability.
• While a t-test is a viable option, the inherent limitations of competition assays with high variability warrant careful consideration.
• Further research may be needed to develop more robust methods for ADA detection in challenging assay conditions.